Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids
Authors
Keywords
-
Journal
SLAS Discovery
Volume 22, Issue 5, Pages 507-515
Publisher
SAGE Publications
Online
2017-05-26
DOI
10.1177/2472555217698817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liquid-based three-dimensional tumor models for cancer research and drug discovery
- (2016) Stephanie L Ham et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids
- (2016) Pradip Shahi Thakuri et al. MOLECULAR PHARMACEUTICS
- Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors
- (2016) Stephanie L. Ham et al. Advanced Healthcare Materials
- Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
- (2016) Kristin Stock et al. Scientific Reports
- Interfacial Tension Effect on Cell Partition in Aqueous Two-Phase Systems
- (2015) Ehsan Atefi et al. ACS Applied Materials & Interfaces
- Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
- (2015) Ryan B. Corcoran et al. JOURNAL OF CLINICAL ONCOLOGY
- Hitting the Target in BRAF-Mutant Colorectal Cancer
- (2015) Ankur K. Nagaraja et al. JOURNAL OF CLINICAL ONCOLOGY
- High Throughput, Polymeric Aqueous Two-Phase Printing of Tumor Spheroids
- (2014) Ehsan Atefi et al. ADVANCED FUNCTIONAL MATERIALS
- Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-cancer Drug Testing in 3D Culture
- (2014) Stephanie Lemmo et al. Cellular and Molecular Bioengineering
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
- (2012) E J Haagensen et al. BRITISH JOURNAL OF CANCER
- Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
- (2012) J. S. Logue et al. GENES & DEVELOPMENT
- Compensatory Pathways in Oncogenic Kinase Signaling and Resistance to Targeted Therapies: Six Degrees of Separation: Figure 1.
- (2012) Livio Trusolino et al. Cancer Discovery
- HDACs and HDAC inhibitors in colon cancer
- (2010) John M. Mariadason Epigenetics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started